Invention Grant
- Patent Title: Ganaxolone for use in prophylaxis and treatment of postpartum depression
-
Application No.: US16705541Application Date: 2019-12-06
-
Publication No.: US11266662B2Publication Date: 2022-03-08
- Inventor: Alex Aimetti , Christopher Cashman , Lorianne Masuoka , Jaakko Lappalainen
- Applicant: Marinus Pharmaceuticals, Inc.
- Applicant Address: US PA Radnor
- Assignee: Marinus Pharmaceuticals, Inc.
- Current Assignee: Marinus Pharmaceuticals, Inc.
- Current Assignee Address: US PA Radnor
- Agency: Hogan Lovells US LLP
- Main IPC: A61K31/57
- IPC: A61K31/57 ; A61P25/24 ; A61K9/00
Abstract:
Uses of ganaxolone in prophylaxis and treatment of postpartum depression are described. A dose of ganaxolone is administered to a female suffering from postpartum depression or at risk of developing postpartum depression in an amount and at a rate sufficient to alleviate at least one symptom of postpartum depression in the female.
Public/Granted literature
- US20200179403A1 GANAXOLONE FOR USE IN PROPHYLAXIS AND TREATMENT OF POSPARTUM DEPRESSION Public/Granted day:2020-06-11
Information query
